Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
35.22
+1.47 (4.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
Agios Pharmaceuticals Employees
As of December 31, 2023, Agios Pharmaceuticals had 386 total employees, including 383 full-time and 3 part-time employees. The number of employees decreased by 7 or -1.78% compared to the previous year.
Employees
386
Change (1Y)
-7
Growth (1Y)
-1.78%
Revenue / Employee
$94,554
Profits / Employee
$1,745,402
Market Cap
2.02B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
AGIO News
- 2 days ago - Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - GlobeNewsWire
- 9 days ago - Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 9 days ago - Agios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint - GlobeNewsWire
- 16 days ago - Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025 - GlobeNewsWire
- 6 weeks ago - Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer - Business Wire
- 7 weeks ago - Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 - GlobeNewsWire
- 2 months ago - European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease - GlobeNewsWire